SCHEMBL6401353

SCHEMBL6401353

CCC(C)[C@H](NC(=O)N1CCN(C)CC1)C(=O)N(CCCc1ccccc1)CS(=O)(=O)Nc1ccc(OC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SIGMAR1 Q99720 1/20 0.39
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
PKM P14618 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
OPRM1 P35372 3/20 0.38
OPRD1 P41143 1/20 0.38
MGAT2 Q10469 1/20 0.37
PSMB11 A5LHX3 1/20 0.37
PSMA7 O14818 1/20 0.37
PSMB1 P20618 1/20 0.37
PSMA1 P25786 1/20 0.37
PSMA2 P25787 1/20 0.37
PSMA3 P25788 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6401366 0.87 KEAP1 (0.41) KMT2AALDH1A1MAPK1MGAT2MMP1
SCHEMBL6401348 0.81 KMT2A (0.39) MEN1KMT2ASIGMAR1CHRM5CHRM1
SCHEMBL6401356 0.80 PKM (0.41) SIGMAR1CHRM5CHRM1CHRM3PKM
SCHEMBL5443509 0.76 CTSS (0.51) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL6403176 0.75 LPAR1 (0.45) KMT2AALDH1A1MMP1
SCHEMBL5443511 0.74 BLM (0.41) PKMALDH1A1NAMPTLMNAMAPT
SCHEMBL6407189 0.72 MMP3 (0.41) KMT2AALDH1A1MMP1
SCHEMBL6409464 0.70 ALOX5 (0.42) KMT2AALDH1A1MMP1MMP9
SCHEMBL6402653 0.70 CTSS (0.47) SIGMAR1LMNAMAPT
SCHEMBL6403175 0.70 L3MBTL1 (0.45) SMN1; SMN2ALDH1A1LMNAMAPTMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900237-B2 Sulfonamide compounds as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-05-31 US claimed
US-20030158231-A1 Sulfonamide compounds as protease inhibitors Celera Corporation 2003-08-21 US claimed
US-6900237-B2 Sulfonamide compounds as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-05-31 US disclosed
US-20030158231-A1 Sulfonamide compounds as protease inhibitors Celera Corporation 2003-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158231-A1 Sulfonamide compounds as protease inhibitors PRSS1, PRSS3, SPINT2 MEN1 4533/4885KMT2A 2789/4885SIGMAR1 2372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.